2-(5-Bromo-7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid
≥95%
- Product Code: 115792
CAS:
393509-23-4
| Molecular Weight: | 312.13 g./mol | Molecular Formula: | C₁₃H₁₁BrFNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16250085 | |
| Melting Point: | Boiling Point: | 506.8°C at 760 mmHg | |
| Density: | 1.7g/cm3 | Storage Condition: | 2-8°C, dry and sealed away from light |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a bromo and fluoro substituent, makes it a valuable intermediate in the design of molecules targeting central nervous system disorders. Researchers often explore its potential in creating compounds with enhanced binding affinity to specific receptors, which could lead to the development of new therapies for conditions such as depression, anxiety, or neurodegenerative diseases. Additionally, its unique tetrahydrocyclopenta[b]indole core is of interest in medicinal chemistry for optimizing pharmacokinetic properties and improving drug efficacy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €101.39 |
+
-
|
| 0.250 | 10-20 days | €172.62 |
+
-
|
| 1.000 | 10-20 days | €466.09 |
+
-
|
2-(5-Bromo-7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a bromo and fluoro substituent, makes it a valuable intermediate in the design of molecules targeting central nervous system disorders. Researchers often explore its potential in creating compounds with enhanced binding affinity to specific receptors, which could lead to the development of new therapies for conditions such as depression, anxiety, or neurodegenerative diseases. Additionally, its unique tetrahydrocyclopenta[b]indole core is of interest in medicinal chemistry for optimizing pharmacokinetic properties and improving drug efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :